CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-17 | Newell Joe Chief Operations Officer | Sale | −3,500 | $15.00 | $53K | 131,424 |
| 2021-04-05 | Newell Joe Chief Operations Officer | Sale | −655 | $14.74 | $10K | 134,924 |
| 2021-03-26 | Koppikar Utpal Chief Financial Officer | Sale | −1,761 | $14.58 | $26K | 172,582 |
| 2021-03-26 | Newell Joe Chief Operations Officer | Sale | −2,640 | $14.58 | $38K | 135,579 |
| 2021-03-15 | Newell Joe Chief Operations Officer | Option exercise | +3,500 | $12.15 | $43K | 145,219 |
| 2021-03-15 | Newell Joe Chief Operations Officer | Sale | −7,000 | $17.41 | $122K | 138,219 |
| 2021-03-15 | Newell Joe Chief Operations Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,791 | 43,250 | ||
| 2021-03-15 | Newell Joe Chief Operations Officer | Option exercise · Employee Stock Option (Right to Buy) | −709 | 12,750 | ||
| 2021-03-02 | Newell Joe Chief Operations Officer | Sale | −1,665 | $16.74 | $28K | 141,719 |
| 2021-03-02 | Koppikar Utpal Chief Financial Officer | Sale | −1,461 | $16.74 | $24K | 174,343 |
| 2021-03-02 | Touchon Pascal President and CEO | Sale | −4,887 | $16.74 | $82K | 367,621 |
| 2021-03-01 | Dupont Jakob EVP, Head of R&D | Grant or award | +53,879 | 100,129 | ||
| 2021-03-01 | Dupont Jakob EVP, Head of R&D | Grant or award · Employee Stock Option (Right to Buy) | +81,327 | 81,327 | ||
| 2021-03-01 | Murugan Amar SVP, GC & Secretary | Grant or award | +41,756 | 97,425 | ||
| 2021-03-01 | Murugan Amar SVP, GC & Secretary | Grant or award · Employee Stock Option (Right to Buy) | +63,028 | 63,028 | ||
| 2021-03-01 | Newell Joe Chief Operations Officer | Grant or award | +37,715 | 143,384 | ||
| 2021-03-01 | Newell Joe Chief Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +56,929 | 56,929 | ||
| 2021-03-01 | Yarema Kristin Chief Commercial Officer | Grant or award | +35,021 | 92,289 | ||
| 2021-03-01 | Yarema Kristin Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +52,862 | 52,862 | ||
| 2021-03-01 | Koppikar Utpal Chief Financial Officer | Grant or award | +45,258 | 175,804 |
Page 15 of 17 · 334 trades